Sanofi CEO Paul Hudson: We have one of the best growth profiles in all of Big Pharma

(4:24)

Sanofi CEO Paul Hudson on R\u0026D Day: We're going to be the world's leading immunology company

(7:37)

Sanofi CEO Paul Hudson on Q3 results: The modernization effort is starting to pay off

(6:27)

Sanofi CEO Paul Hudson: We've got perhaps the world's best immunology pipeline

(5:)

Sanofi CEO Paul Hudson on Q1 results: Hope to gather even more momentum later this year

(3:1econd)

Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

(8:54)

What's the 'New Sanofi' Like? Let CEO Paul Hudson Explain. | At Barron's

(19:37)

CEO Paul Hudson on Sanofi’s Bold New Strategy and “Snackable AI”

(3:13)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

What is behind pharmaceutical giant Sanofi's 1 billion euro investment in China?

(5:33)

Goldman's David Kostin on US Earnings, Tariffs, Mid-Cap Stocks

(6:44)

How Sanofi Created A Company-Wide AI Strategy

(5:37)

Recordati Rare Diseases

(8:)

Sanofi Long Term Plan Presentation

(51:47)

CEDR \u0026 Sanofi in Partnership

(21:39)

Sanofi chief lauds ‘significant China milestone’

(3:10)

Sanofi Success Story | French multinational Pharmaceutical industry company | Paul Hudson

(3:45)

Sanofi Chief Digital Officer Emmanuel Frenehard on the company’s comprehensive approach to AI

(10:57)

Sanofi CEO: We’re buying cancer-biotech firm Synthorx for $2.5 billion

(5:45)

Special Interview | Sanofi to Become No 1 in Healthcare in KSA by End of 2024 CEO: Paul Hudson

(9:20)

Episode 3: Innovating for a Healthier Future with Sanofi's CEO

(8:34)

Sanofi CEO Paul Hudson on Q3 results: Increased R\u0026D spending will impact 2024 profit

(7:26)

Sanofi’s CEO on How Company Culture Can Thrive in a Distributed, Hybrid World

(32:36)

Sanofi CEO Paul Hudson on the coronavirus, the FDA, drug development and more

(5:48)

Sanofi CEO: Real breakthrough in RSV treatment is 'right around the corner'

(4:3)

Sanofi CEO Paul Hudson on Q2 results: Our underlying growth is still high-single digit

(5:51)

Sanofi CEO Paul Hudson on cancer research, Covid-19 vaccine and more

(4:13)

Sanofi CEO Paul Hudson on COVID-19 and potential vaccine (Full Stream 11/10)

(1:27:5)

Recordati CEO sees 'substantial opportunity' in Sanofi drug purchase

(3:47)